Dimensional Fund Advisors
DNA icon

Dimensional Fund Advisors’s Ginkgo Bioworks DNA Stock Holding History

Dimensional Fund Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.48M Buy
351,200
+224,152
+176% +$1.87M ﹤0.01% 2619
2026
Q1 		$779K Buy
127,048
+24,434
+24% +$203K ﹤0.01% 2884
2025
Q4 		$853K Buy
102,614
+89,298
+671% +$962K ﹤0.01% 2882
2025
Q3 		$194K Buy
13,316
+519
+4% +$6.21K ﹤0.01% 3124
2025
Q2 		$144K Hold
12,797
– – ﹤0.01% 3150
2025
Q1 		$72.9K Buy
+12,797
New +$130K ﹤0.01% 3235

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Dimensional Fund Advisors's DNA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Ginkgo Bioworks (DNA) stake by 176% in Q2 2026, buying an estimated $1.87M and bringing the position to 351,200 shares worth $3.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2619.

Dimensional Fund Advisors first reported a position in DNA in Q1 2025 and has held it in 6 quarters since. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Dimensional Fund Advisors held 351,200 shares of Ginkgo Bioworks worth $3.48M as of Q2 2026.
  • Dimensional Fund Advisors bought 224,152 Ginkgo Bioworks shares in Q2 2026, an estimated $1.87M.
  • Ginkgo Bioworks made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2619 holding.
  • Dimensional Fund Advisors first reported a position in Ginkgo Bioworks in Q1 2025 and has held it in 6 quarters since.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.